Effects of six months of vitamin D supplementation in patients with heart failure: A randomized double-blind controlled trial

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 24, Issue 8, 2014, Pages 861-868

  Dalbeni, A ^a   Scaturro, G ^a   Degan, M ^a   Minuz, P ^a   Delva, P ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Ejection fraction; Heart failure; Vitamin D supplements

Indexed keywords

CALCIUM; CHOLESTEROL; COLECALCIFEROL; GLUCOSE; PARATHYROID HORMONE; PLACEBO; POTASSIUM; VITAMIN D; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER; COLLAGEN TYPE 1; RENIN;

AGED; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION AND FOLLOW UP; FEMALE; HEART FAILURE; HEART VENTRICLE SEPTUM; HUMAN; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VERY ELDERLY; VITAMIN SUPPLEMENTATION; ANALOGS AND DERIVATIVES; BLOOD; BLOOD PRESSURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; MIDDLE AGED; TREATMENT OUTCOME; VITAMIN D DEFICIENCY;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY MASS INDEX; CALCIUM; CHOLECALCIFEROL; COLLAGEN TYPE I; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PARATHYROID HORMONE; RENIN; TREATMENT OUTCOME; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84904725012     PISSN: 09394753     EISSN: 15903729     Source Type: Journal    
DOI: 10.1016/j.numecd.2014.02.015     Document Type: Article

References (30)

1. Mosterd A., Hoes A.W. Clinical epidemiology of heart failure. Heart 2007, 93:1137-1146.
2. Peeters A., Barendregt J.J., Willekens F., Mackenbach J.P., Al Mamun A., Bonneux L. Obesity in adulthood and its consequences for the expectancy: a life-table analysis. Ann Intern Med 2003, 138:24-32.
3. Lee J.H., O'Keefe J.H., Bell D., Hensrud D.D., Holick M.F. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?. J Am Coll Cardiol 2008, 52:1949-1956.
4. Zittermann A., Iodice S., Pilz S., Grant W.B., Bagnardi V., Gandini S. Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am J Clin Nutr 2012, 95:91-100.
5. Melamed M.L., Michos E.D., Post W., Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008, 168:1629-1637.
6. Tishkoff D.X., Nibbelink K.A., Holmberg K.H., Dandu L., Simpson R.U. Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocytes contractility. Endocrinology 2008, 149:558-564.
7. Rahman A., Hershey S., Ahmed S., Nibbelink K., Simpson R.U. Heart extracellular matrix gene expression profile in the vitamin D receptor knockout mice. J Steroid Biochem Mol Biol 2007, 103:416-419.
8. O'Connell T.D., Simpson R.U. Immunochemical identification of the 1,25-dihydroxyvitamin D3 receptor protein in human heart. Cell Biol Int 1996, 20:621-624.
9. Gupta G.K., Agrawal T., DelCore M., Mohiuddin S.M., Agrawal D.K. Vitamin D deficiency induces cardiac hypertrophy and inflammation in epicardial adipose tissue in hypercholesterolemic swine. Exp Mol Pathol 2012, 93:82-90.
10. Lang Roberto M., Bierig Michelle, Devereux Richard B., et al. Recommendations for chamber quantification. Eur J Echocardiogr 2006, 7(2):79-108. American Society of Echocardiography's Nomenclature and Standards Committee, Task Force on Chamber Quantification, American College of Cardiology Echocardiography Committee, American Heart Association, European Association of Echocardiography, European Society of Cardiology.
11. López B., González A., Díez J. Circulating biomarkers of collagen metabolism in cardiac diseases. Circulation 2010, 121:1645-1654.
12. WHO scientific Group on the Prevention and management of osteoporosis: report of a WHO scientific group 2003, 1-164. World Health Organization, Geneva.
13. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A. Evaluation, treatment and prevention of vitamin D deficiency: an Endocrine Society clinical practice guide. J Clin Endocrinol Metab 2011, 96:1911.
14. Dawson-Hughes B., Heaney R.P., Holick M.F. Estimates of optimal vitamin D statu. Osteoporos Int 2005, 16:713.
15. Schleithoff S.S., Zittermann A., Tenderich G., Berthold H.K., Stehle P., Koerfer R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2006, 83:754-759.
16. Witte K.K., Nikitin N.P., Parker A.C., et al. The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure. Eur Heart J 2005, 26:2238-2244.
17. Zia A.A., Komolafe B.O., Moten M., et al. Supplemental vitamin D and calcium in the management of African Americans with heart failure having hypovitaminosis D. Am J Med Sci 2011, 341:113-118.
18. Shedeed S.A. Vitamin D supplementation in infants with chronic congestive heart failure. Pediatr Cardiol 2012, 33:713-719.
19. Witham M.D., Crighton L.J., Gillespie N.D., Struthers A.D., McMurdo M.E.T. The effects of vitamin D supplementation on physical function and quality of life in older patients with heart failure. A randomized controlled trial. Circ Heart Fail 2010, 3:195-201.
20. Gotsman I., Shauer A., Zwas D.R., et al. Vitamin D deficiency is a predictor of reduced survival in patients with heart failure; vitamin D supplementation improves outcome. Eur J Heart Fail 2012, 14:357-366.
21. Resnick L.M., Muller F.B., Laragh J.H. Calcium regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Ann Intern Med 1986, 110:649-654.
22. Li Y.C., Kong J., Wei M., Chen Z.F., Liu S.Q., Cao L.P. 1,25-Dihydroxyvitamin D (3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002, 110:229-238.
23. Chen S., Glenn D.J., Ni W., et al. Expression of the vitamin D receptor is increased in the hypertrophic heart. Hypertension 2008, 52:1106-1112.
24. Krause R., Buhring M., Hopfenmuller W., Holick M.F., Sharma A.M. Ultraviolet B and blood pressure. Lancet 1998, 352:709-710.
25. Rauchhaus M., Doehner W., Francis D.P. Plasma cytochine parameters and mortality in patients with chronic heart failure. Circulation 2000, 102:3060-3067.
26. Zhu Y., Mahon B.D., Froicu M., Cantorna M.T. Calcium and 1 alpha, 25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease. Eur J Immunol 2005, 35:217-224.
27. Santillán G.E., Vazquez G., Boland R.L. Activation of a beta-adrenergic-sensitive signal transduction pathway by the secosteroid hormone 1,25-(OH) 2-vitamin D3 in chick heart. J Mol Cell Cardiol 1999, 31:1095-1104.
28. Delva P., Lechi A., Pastori C., et al. Collagen I and III mRNA gene expression and cell growth potential of skin fibroblasts in patients with essential hypertension. J Hypertens 2002, 20:1393-1399.
29. Ho C.Y., Lopez B., Coelho-Filho O.R., et al. Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. NEJM 2010, 363:552-563.
30. Zittermann A., Schleithoff S.S., Tenderich G., Berthold H.K., Körfer R., Stehle P. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure?. J Am Coll Cardiol 2003, 41(1):105-112.